Kelsey Stephen Michael 4
4 · Revolution Medicines, Inc. · Filed Sep 18, 2025
Insider Transaction Report
Form 4
Kelsey Stephen Michael
See Remarks
Transactions
- Sale
Common Stock
2025-09-16$45.82/sh−5,367$245,942→ 284,047 total
Footnotes (2)
- [F1]Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023.
- [F2]Includes 84,000 restricted stock units.